Neurokine Therapeutics LLC

Philadelphia, PA

UEI
E3KLEENGVBR5
CAGE
7WKJ3
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3711 Market St, Philadelphia, PA 19104, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a stress kinase inhibitor therapeutic candidate for alzheimer's disease and related dementia R44AG071388 National Institute on Aging (NIH) $2,711,697
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate R42AG062095 National Institute on Aging (NIH) $3,155,525

Quick answers

Is Neurokine Therapeutics LLC registered in SAM.gov?

Yes. Neurokine Therapeutics LLC's SAM.gov registration is active through November 19, 2026.

What is Neurokine Therapeutics LLC's most recent federal award?

Neurokine Therapeutics LLC's most recent federal grant award is Development of a stress kinase inhibitor therapeutic candidate for alzheimer's disease and related dementia (R44AG071388), from National Institute on Aging (NIH), on September 30, 2020.

On GovTribe

See Neurokine Therapeutics LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login